Date | Time | Source | Headline | Symbol | Company |
05/20/2024 | 8:13PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:ALPN | Alpine Immune Sciences Inc |
05/20/2024 | 8:12PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:ALPN | Alpine Immune Sciences Inc |
05/20/2024 | 8:05PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:ALPN | Alpine Immune Sciences Inc |
05/20/2024 | 8:03PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:ALPN | Alpine Immune Sciences Inc |
05/20/2024 | 8:02PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:ALPN | Alpine Immune Sciences Inc |
05/20/2024 | 8:53AM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:ALPN | Alpine Immune Sciences Inc |
05/20/2024 | 8:52AM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:ALPN | Alpine Immune Sciences Inc |
05/20/2024 | 8:51AM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:ALPN | Alpine Immune Sciences Inc |
05/20/2024 | 8:50AM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:ALPN | Alpine Immune Sciences Inc |
05/20/2024 | 8:50AM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:ALPN | Alpine Immune Sciences Inc |
05/20/2024 | 8:49AM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:ALPN | Alpine Immune Sciences Inc |
05/20/2024 | 8:49AM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:ALPN | Alpine Immune Sciences Inc |
05/20/2024 | 8:48AM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:ALPN | Alpine Immune Sciences Inc |
05/20/2024 | 8:47AM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:ALPN | Alpine Immune Sciences Inc |
05/20/2024 | 8:47AM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:ALPN | Alpine Immune Sciences Inc |
05/20/2024 | 8:46AM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:ALPN | Alpine Immune Sciences Inc |
05/20/2024 | 8:45AM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:ALPN | Alpine Immune Sciences Inc |
05/20/2024 | 8:45AM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:ALPN | Alpine Immune Sciences Inc |
05/20/2024 | 8:44AM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:ALPN | Alpine Immune Sciences Inc |
05/20/2024 | 8:43AM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:ALPN | Alpine Immune Sciences Inc |
05/20/2024 | 8:43AM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:ALPN | Alpine Immune Sciences Inc |
05/20/2024 | 8:42AM | Edgar (US Regulatory) | Form POS AM - Post-Effective amendments for registration statement | NASDAQ:ALPN | Alpine Immune Sciences Inc |
05/20/2024 | 8:41AM | Edgar (US Regulatory) | Form POS AM - Post-Effective amendments for registration statement | NASDAQ:ALPN | Alpine Immune Sciences Inc |
05/20/2024 | 8:38AM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:ALPN | Alpine Immune Sciences Inc |
05/20/2024 | 8:27AM | Edgar (US Regulatory) | Form SC 14D9/A - Solicitation, recommendation statements: [Amend] | NASDAQ:ALPN | Alpine Immune Sciences Inc |
05/10/2024 | 7:26PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:ALPN | Alpine Immune Sciences Inc |
05/10/2024 | 7:25PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:ALPN | Alpine Immune Sciences Inc |
05/10/2024 | 7:22PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:ALPN | Alpine Immune Sciences Inc |
05/10/2024 | 8:30AM | Edgar (US Regulatory) | Form SC 14D9/A - Solicitation, recommendation statements: [Amend] | NASDAQ:ALPN | Alpine Immune Sciences Inc |
05/09/2024 | 4:22PM | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | NASDAQ:ALPN | Alpine Immune Sciences Inc |